Sodium chloride and Xiidra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sodium chloride (sodium chloride) and Xiidra (lifitegrast). Common drug interactions include urinary retention among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Sodium chloride and Xiidra. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Sodium chloride?

Sodium chloride has active ingredients of sodium chloride. eHealthMe is studying from 39,559 Sodium chloride users. Check the latest studies of Sodium chloride.

What is Xiidra?

Xiidra has active ingredients of lifitegrast. eHealthMe is studying from 15,244 Xiidra users. Check the latest studies of Xiidra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

59 people who take Sodium chloride and Xiidra together, and have interactions are studied.

Sodium chloride and Xiidra drug interactions.

What are the common drug interactions of Sodium Chloride and Xiidra, by gender? *:

female:

  1. Urinary retention (the inability to completely or partially empty the bladder)
  2. Urinary tract infection
  3. Weight increased
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  5. Alopecia (absence of hair from areas of the body)
  6. Blood pressure increased
  7. Compression fracture (fracture due to pressure caused by injury)
  8. Concussion (short loss of normal brain function in response to a head injury)
  9. Forearm fracture (fracture in between wrist to elbow)
  10. Infusion site bruising

male:

  1. Headache (pain in head)
  2. Dyspnoea (difficult or laboured respiration)
  3. Fall
  4. Gait disturbance
  5. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  6. Pharyngeal mass
  7. Renal impairment (severely reduced kidney function)
  8. Sinus disorder (disease of sinus)
  9. Vomiting
  10. Back pain

What are the common drug interactions of Sodium Chloride and Xiidra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Drug hypersensitivity
  2. Arthralgia (joint pain)
  3. Asthma
  4. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  5. Device occlusion
  6. Dizziness
  7. Ear congestion
  8. Fall
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

50-59:

  1. Arthralgia (joint pain)
  2. Asthenia (weakness)
  3. Back disorder
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  6. Dizziness
  7. Dry eye (lack of adequate tears)
  8. Fatigue (feeling of tiredness)
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Influenza

60+:

  1. Fall
  2. Headache (pain in head)
  3. Renal impairment (severely reduced kidney function)
  4. Pain
  5. Compression fracture (fracture due to pressure caused by injury)
  6. Forearm fracture (fracture in between wrist to elbow)
  7. Infusion site extravasation (flow of (blood or lymph) from infusion site)
  8. Migraine (headache)
  9. Rash
  10. Seasonal allergy (allergic condition due to certain season)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 22 people, 37.29%
  2. Immune System Disorder: 6 people, 10.17%
  3. Hereditary Angioedema (recurrent episodes of severe swelling): 5 people, 8.47%
  4. Pemphigoid (tense blisters on the skin): 4 people, 6.78%
  5. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 4 people, 6.78%
  6. Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 4 people, 6.78%
  7. Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 4 people, 6.78%
  8. Iridocyclitis (inflammation of the iris and ciliary body of the eye): 4 people, 6.78%
  9. Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.08%
  10. Primary Immunodeficiency Syndrome: 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Sodium chloride and Xiidra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sodium chloride and Xiidra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sodium chloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xiidra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sodium chloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xiidra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sodium chloride and lifitegrast (the active ingredients of Sodium chloride and Xiidra, respectively), and Sodium chloride and Xiidra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: